Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia
  • Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program

    ESC Heart Failure Date published:
  • Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program

    American Journal of Kidney Diseases Date published:
  • Estimating the potential impact of Australia’s reformulation programme on households’ sodium purchases

    BMJ Nutrition, Prevention & Health Date published:
  • Protocol for a randomized controlled trial to test the acceptability and adherence to 6-months of walnut supplementation in Chinese adults at high risk of cardiovascular disease

    Nutrition Journal Date published:
  • Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol

    American Heart Journal Date published:
  • Circulating Metabolites to Predict Renal Outcomes in CANVAS Type 2 Diabetes Mellitus Population

    Date published:
  • Canagliflozin and Cardiovascular Outcomes in Patients With and Without Peripheral Artery Disease At Baseline: Data from the CANVAS Program and CREDENCE Trials

    Heart, Lung and Circulation Date published:
  • SSaSS - The China salt substitute and stroke study

    Open Science Framework Date published:
  • Projected effects on salt purchases following implementation of a national salt reduction policy in South Africa

    Public Health Nutrition Date published:
  • Influence of sugar label formats on consumer understanding and amount of sugar in food choices: a systematic review and meta-analyses

    Nutrition Reviews Date published:
  • Feasibility and validity of using death surveillance data and SmartVA for fact and cause of death in clinical trials in rural China: a substudy of the China salt substitute and stroke study (SSaSS)

    Journal of Epidemiology and Community Health Date published:
  • Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019

    Journal of the American College of Cardiology Date published:
  • The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program

    International Journal of Cardiology Date published:
  • The impact of voluntary front-of-pack nutrition labelling on packaged food reformulation: A difference-in-differences analysis of the Australasian Health Star Rating scheme

    PLOS Medicine Date published:
  • Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2

    Clinical Journal of the American Society of Nephrology Date published:
  • Seventeen-Year Associations between Diet Quality Defined by the Health Star Rating and Mortality in Australians: The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)

    Current Developments in Nutrition Date published: